Marketwire (Thu, 8:30AM)
Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
39 people get DXR articles and Market Currents by email alert.
Get email alerts on DXR »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
Marketwire (Jan 31, 2013)
-
Marketwire (Nov 29, 2012)
-
Marketwire (Nov 19, 2012)
-
Marketwire (Nov 8, 2012)
-
Marketwire (Aug 3, 2012)
To learn more about Seeking Alpha Pro, click here.
-
Daxor Corp: Making Money the Wrong WaySaj Karsan • Sun, Sep 26, 2010
-
Pharmaceutical And Biotechnology Insider Buys Last WeekGutone • Mon, Jul 2, 2012
-
Pharmaceutical And Biotechnology Companies Purchased By Insiders TodayGutone • Thu, Jun 21, 2012
-
Healthcare Dogs Stay Steady In AprilFredrik Arnold • Thu, May 24, 2012
-
February Summaries For 8 Sector Dogs And The DowFredrik Arnold • Sun, Mar 11, 2012
There are no Transcripts on DXR.
-
Marketwire (Jan 31, 2013)
-
Marketwire (Nov 29, 2012)
-
Marketwire (Nov 19, 2012)
-
Marketwire (Nov 8, 2012)
-
Marketwire (Aug 3, 2012)
-
Marketwire (Jul 12, 2012)
-
Marketwire (Jun 21, 2012)
-
Marketwire (Mar 28, 2012)
-
Marketwire (Mar 23, 2012)
-
Marketwire (Mar 23, 2012)
DXR vs. ETF Alternatives
Company Description
Currently, there's no company description for DXR.
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Thursday, November 29, 2012, 8:51 AM Daxor (DXR) declares $0.10/share quarterly dividend, in line with previous. Forward yield 2.55%. For shareholders of record Dec 11. Payable Dec 27. Ex-div date Dec 07. (PR) Comment! [Dividends]
- Friday, August 3, 2012, 8:50 AM Daxor (DXR) declares $0.15/share quarterly dividend. For shareholders of record Aug 14. Payable Aug 24. Ex-div date Aug 10. (PR) Comment! [Dividends]
- Tuesday, December 13, 2011, 11:51 AM Medical instrumentation and biotechnology company Daxor (DXR +2.4%) gains after saying it's received a trial agreement from the Washington, DC VA Medical Center. Comment! [On the Move, Healthcare]